BioTelemetry, Inc. Reports Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Wall St rises as softer jobs data calms rate-hike fears
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil falls to four-month low as US, Iran conclude talks in Doha
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Whirlpool to close Mexico plant, expects $165M restructuring cost
- Meta Platforms stock surges 8% on cloud business plans
- Wall Street ends choppy session lower as tech shares drop
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
BioTelemetry (BEAT) Tops Q2 EPS by 8c
July 30, 2019 4:11 PM EDTBioTelemetry (NASDAQ: BEAT) reported Q2 EPS of $0.53, $0.08 better than the analyst estimate of $0.45. Revenue for the quarter came in at $111.8 million versus the consensus estimate of $111.11 million.
Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented: Our growth momentum continued in the second quarter, with revenue growth of 10%, enabling us to achieve the high end of our guidance. This revenue growth was... More
